MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: A meta-analysis.

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)

The MDR1 G2677T/A and C3435T polymorphisms might be a risk factor for resistance to IM in Caucasian CML patients.

Keyphrases